73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Editorial: GBP3-STING interaction in glioblastoma coordinates poor response to temozolomide

Editorial: GBP3-STING interaction in glioblastoma coordinates poor response to temozolomide

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncotarget, titled "GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative

Editorial: GBP3-STING interaction in glioblastoma coordinates poor response to temozolomide

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncotarget, titled "GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative
Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0
New blood test developed to diagnose ovarian cancer

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1
Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

by Sabine Waasdorp,Leiden UniversityCredit: Unsplash/CC0 Public DomainMany people think heavy metals are poisonous and always harm people and the environment. The reality is more nuanced, says P

Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

by Sabine Waasdorp,Leiden UniversityCredit: Unsplash/CC0 Public DomainMany people think heavy metals are poisonous and always harm people and the environment. The reality is more nuanced, says P
Some cancer patients can find it hard to tell family and friends

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.
Potential new series of drugs targeting cancer-driving protein BCL6

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /
Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02
Study finds providers use prostate cancer screening tests, even when they provide little value to patients

Study finds providers use prostate cancer screening tests, even when they provide little value to patients

byWake Forest University Baptist Medical CenterChris Gillette, Ph.D., associate professor of PA Studies for Wake Forest University School of Medicine, collaborates with colleagues. Credit: Wake

Study finds providers use prostate cancer screening tests, even when they provide little value to patients

byWake Forest University Baptist Medical CenterChris Gillette, Ph.D., associate professor of PA Studies for Wake Forest University School of Medicine, collaborates with colleagues. Credit: Wake
Targeting mutation slows breast cancer spread, study finds

Targeting mutation slows breast cancer spread, study finds

Credit: Pixabay/CC0 Public DomainThe progression of certain types of breast cancers can be slowed by identifying a particular genetic mutation and then quickly adapting treatment, a first-of-its-kind

Targeting mutation slows breast cancer spread, study finds

Credit: Pixabay/CC0 Public DomainThe progression of certain types of breast cancers can be slowed by identifying a particular genetic mutation and then quickly adapting treatment, a first-of-its-kind
FAAH inhibition ameliorates murine breast cancer: Study

FAAH inhibition ameliorates murine breast cancer: Study

by Impact Journals LLCAn overview of the endocannabinoid pathway and molecules tested in this study. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28534A new research paper titled &quo

FAAH inhibition ameliorates murine breast cancer: Study

by Impact Journals LLCAn overview of the endocannabinoid pathway and molecules tested in this study. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28534A new research paper titled &quo
Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review